New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Shineco, Inc.
SISI
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

26M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Feb 2025

26M

Drug Manufacturers - Specialty & Generic

Next Earning date - 13 Feb 2025

1.50USD

Shape0.06 ( 4.17%)
moonAfter-hours 1.48$arrow-left-down-0.01 (-1.00%)
Market Closed (as of Feb 06, 21:00 EDT)
favorite-chart

Relative Strenght

2
favorite-chart

Volume Buzz

-82%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

99%

Quote Panel

Shape
Updated February 6, 2025
1W -0.66 % 1M -25.37 % 3M -54.41 % 1Y -95.44 %

Key Metrics

Shape
  • Market Cap

    25.77M


  • Shares Outstanding

    17.18M


  • Share in Float

    15.23M


  • Dividende

    0


  • Earning Date

    13 Feb 2025


  • Price Target

    1.5


  • Average Volume

    326938


  • Beta

    -0.003


  • Range

    1.38-117.648


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.biosisi.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

SISI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

Shape-49%

2024-Revenue

$673K

Shape36%

2024-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+157%

8.66
vs -15.09

Q3.22

arrow
arrow

N/A

-40.77
vs -318.94

Q4.22

arrow
arrow

N/A

-38.37
vs NA

Q1.23

arrow
arrow

N/A

-31.18
vs -71.94

Q2.23

arrow
arrow

N/A

-1.79
vs 8.66

Q3.23

arrow
arrow

N/A

-26.38
vs -40.77

Q4.23

arrow
arrow

N/A

-201.44
vs -38.37

Q1.24

arrow
arrow

N/A

-12.47
vs -31.18

Q2.24

arrow
arrow

N/A

-3.79
vs -1.79

Q3.24

arrow
arrow

N/A

-2.34
vs -26.38

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+103%

206K  vs -6175397

Q3.22

arrow
arrow

-15%

535.7K  vs 629.8K

Q4.22

arrow
arrow

-26%

539.2K  vs 732.6K

Q1.23

arrow
arrow

+12%

693K  vs 618.1K

Q2.23

arrow
arrow

-691%

-1217501.00  vs 206K

Q3.23

arrow
arrow

+207%

1.6M  vs 535.7K

Q4.23

arrow
arrow

+328%

2.3M  vs 539.2K

Q1.24

arrow
arrow

+95%

1.3M  vs 693K

Q2.24

arrow
arrow

+469%

4.5M  vs -1217501

Q3.24

arrow
arrow

+32%

2.2M  vs 1.6M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-5%

-0.05
vs -0.06

Q1.23

arrow
arrow

-7%

-0.07
vs -0.05

Q2.23

arrow
arrow

-11%

-0.11
vs -0.07

Q3.23

arrow
arrow

-9%

-0.09
vs -0.11

Q4.23

arrow
arrow

-11%

-0.11
vs -0.09

Q1.24

arrow
arrow

-9%

-0.09
vs -0.11

Q2.24

arrow
arrow

-77%

-0.77
vs -0.09

Q3.24

arrow
arrow

-6%

-0.06
vs -0.77

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

4

4
vs 3

33%

Q2.22

arrow
arrow

3

3
vs 4

-25%

Q3.22

arrow
arrow

3

3
vs 3

NA

Q4.22

arrow
arrow

3

3
vs 3

NA

Q1.23

arrow
arrow

3

3
vs 3

NA

Q2.23

arrow
arrow

3

3
vs 3

NA

Q3.23

arrow
arrow

6

6
vs 3

100%

Q4.23

arrow
arrow

4

4
vs 6

-33%

Earnings Growth

Latest News